ECM
HALO icon

Everence Capital Management’s Halozyme HALO Stock Holding History

Everence Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Hold
4,391
– – 0.02% 573
2026
Q1 		$284K Sell
4,391
-719
-14% -$50.7K 0.02% 592
2025
Q4 		$344K Hold
5,110
– – 0.02% 534
2025
Q3 		$375K Hold
5,110
– – 0.02% 499
2025
Q2 		$266K Hold
5,110
– – 0.02% 629
2025
Q1 		$326K Hold
5,110
– – 0.02% 531
2024
Q4 		$244K Buy
+5,110
New +$262K 0.02% 681

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return

Everence Capital Management's HALO Position: Q2 2026 in Review

Everence Capital Management held its Halozyme (HALO) position steady in Q2 2026 at 4,391 shares worth $344K. The position accounts for 0.02% of the portfolio, ranked #573.

Everence Capital Management first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. The position peaked at $375K in Q3 2025. 342 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Everence Capital Management held 4,391 shares of Halozyme worth $344K as of Q2 2026.
  • Everence Capital Management left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up 0.02% of Everence Capital Management's portfolio in Q2 2026, its #573 holding.
  • Everence Capital Management first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • Everence Capital Management's Halozyme position peaked at $375K in Q3 2025.
  • 342 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.